Get 25% off STAT+ and access the top stories from December

Get 25% off an annual STAT+ subscription and read more of our award-winning journalism.

My Account    STAT+ Check out last month's top stories. If you like what you see, join the STAT+ community today – and enjoy 25% off your first year with code LOYAL25. Drew Angerer/Getty Images 1   Congress strikes deal to rein in PBMs after years of debate By Rachel Cohrs Zhang Mike Reddy for STAT 2   'Significant talent shortage' threatens the rise of radiopharmaceuticals By Allison DeAngelis Ruby Wallau for STAT 3   Editas Medicine lays off 65% of staff and shelves lead gene-editing program By Jason Mast Subscribe to STAT+ Enjoy discounts on STAT Reports and events, free access to premium data tools, and daily coverage of the life sciences. SUBSCRIBE NOW More Top Stories 4   Worst Biopharma CEO of 2024? It's no contest By Adam Feuerstein 5   Who stood out as Best Biopharma CEO of 2024? By Adam Feuerstein 6   Why Applied Therapeutics has a credibility problem By Adam Feuerstein 7   AI versus AI: The emerging arms race over health insurance denials By Casey Ross 8   UnitedHealthcare CEO's killing lays bare rising security risks facing health care leaders By Annalisa Merelli and Jonathan Wosen 9   Truth-teller or reflexive contrarian: Which Marty Makary would run the FDA? By Lizzy Lawrence 10   Inside a Nobel-winning marriage: They see each other as scientific equals, even if the prize committee doesn't By Megan Molteni read more STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us